Gerresheimer
Gerresheimer provides primary packaging solutions including closures and accessories, as well as drug delivery systems and medical devices. Its products include infusion, dropper and syrup bottles, tablet containers, vials, syringes, pens, autoinjectors, inhalers, ampoules, cartridges and on-body devices.
Associated Companies
Bormioli Pharma
Corporate Headquarters
Gerresheimer AG
Peter-Müller-Straße 3
40468 Düsseldorf
Germany
Gerresheimer offers an extensive portfolio of primary packaging solutions including closures and accessories, as well as drug delivery systems and medical devices, for partners across the global pharma, biotech and cosmetics industries.
Its products include infusion, dropper and syrup bottles, tablet containers, vials, syringes, pens, autoinjectors, inhalers, ampoules, cartridges, on-body devices as well as digital solutions for therapy support. It supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability.
Gerresheimer has 39 production sites in Europe, America and Asia, and produces locally for regional markets.
Together with Bormioli Pharma, which it acquired in 2025, the group generated revenues of around €2.4 billion in 2024 and, as of June 2026, employed more than 13,000 people.
Gerresheimer AG is listed on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).
Articles by Gerresheimer
